Crescent Biopharma (CBIO) Return on Equity [ROE] (2014 - 2026)
Crescent Biopharma's Return on Equity [ROE] came in at -93.99% for Q2 2026, down 18.54 percentage points from -75.46% a year earlier and down 11.23 percentage points from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025, Crescent Biopharma's Return on Equity [ROE] was -164.18%, up 166.32 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of -128.04 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -330.49% in FY2024 (-239.77 pp), -90.72% in FY2023 (-15.74 pp), -74.98% in FY2022 (-14.52 pp) and -60.46% in FY2021 (-24.32 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q3 2024.
- Year-over-year, Return on Equity [ROE] increased in two of the last four quarters, with an average year-over-year change of +24.28 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2025 (a gain of 379.88 percentage points), and the weakest in Q3 2024 (a drop of 348.49 percentage points).
- Business Quant data shows CBIO's Return on Equity [ROE] at -82.76% (Q1 2026), -87.06% (Q4 2025) and -43.72% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Crescent Biopharma | 397.47 Mn | -309.83 Mn | - | -93.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -93.99% |
| Mar 31, 2026 | -82.76% |
| Dec 31, 2025 | -87.06% |
| Sep 30, 2025 | -43.72% |
| Jun 30, 2025 | -75.46% |
| Sep 30, 2024 | -423.60% |
| Jun 30, 2024 | -159.73% |
| Mar 31, 2024 | -110.74% |
| Dec 31, 2023 | -86.86% |
| Sep 30, 2023 | -75.12% |
| Jun 30, 2023 | -63.92% |
| Mar 31, 2023 | -80.67% |
| Dec 31, 2022 | -102.56% |
| Sep 30, 2022 | -103.74% |
| Jun 30, 2022 | -101.29% |
| Mar 31, 2022 | -85.28% |
| Dec 31, 2021 | -71.20% |
| Sep 30, 2021 | -58.96% |
| Jun 30, 2021 | -48.83% |
| Mar 31, 2021 | -45.50% |
API Access
Crescent Biopharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();